Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
GRASP logo

We are celebrating a fantastic end to the month and seeing January out with a bang after a bumper recruitment day on 31st January. We recruited 33 patients in January (including an amazing 7 patients on 31st January alone), which smashed our previous record of 25 and enabled us to beat our monthly recruitment target. Thanks and congratulations to all of the sites involved in our record-breaking month – with more sites opening to recruitment we hope to beat this in February!

We are currently open to recruitment in 15 sites, with a further 5 to come on board in the coming months. GRASP is recruiting adults with a new episode of shoulder pain attributable to a rotator cuff disorder.

 

Similar stories

AVID-CC trial opens to recruitment!

OCTRU

The AVID-CC trial has received OCTRU Green Light approval and is now open to recruitment!

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research Trauma

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!

OCTRU

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand

Main OCTRU

Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.